Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease. [electronic resource]
Producer: 20190410Description: 14-16 p. digitalISSN:- 1537-162X
- Aged
- Antiparkinson Agents -- administration & dosage
- Blepharospasm -- chemically induced
- Botulinum Toxins, Type A -- adverse effects
- Carbidopa -- adverse effects
- Drug Combinations
- Dyskinesias -- drug therapy
- Humans
- Levodopa -- administration & dosage
- Male
- Middle Aged
- Parkinson Disease -- drug therapy
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.